Private Credit’s Q2 Cracks: Ares Caps ASIF Redemptions
Q2 2026 private-credit reads: Ares Capital core EPS $0.47, ASIF pro-rates 14.4% redemption bid, Proskauer default index 2.51%. Where the stress is showing up.
Capital Markets
The Index Effect: How S&P 500 Additions Move Stocks
How S&P 500 inclusion moves a stock: the pre-announcement drift, run-up to effective date, decay after, and why the effect has shrunk since 2010.
SpaceX Prices $25B Inaugural Bond on $89B in Orders
SpaceX sold $25B across five tranches in its first-ever bond sale, drawing nearly $89B in orders and tightening spreads 25 bps from talk.
SK Hynix Plans Record $29B Nasdaq ADR Listing in July
SK Hynix will raise up to $29.43B via a Nasdaq ADR listing on July 10, eclipsing Alibaba’s 2014 NYC debut as the largest foreign-issuer ADR ever.
AbbVie Buys Apogee for $10.9B; ABBV Pops 6%
AbbVie agreed to buy Apogee Therapeutics for $10.9B all-cash at a 49% premium, adding IL-13 candidate zumilokibart to challenge Dupixent. ABBV rose 6%.
CRH Nears $8B+ Deal for Arcosa, Its Largest-Ever Takeover
Building-materials giant CRH is reportedly close to buying Arcosa for $8B+, what would be its largest acquisition and a major US infrastructure roll-up.
Fox to Buy Roku for $22B; Arb Spread Hints at Deal Doubt
Fox’s $160-a-share cash-and-stock bid for Roku closed Friday at $138.07 — a 14% spread that says traders are not convinced the deal closes clean.
Kalshi Eyes IPO at $22B Valuation as Revenue Triples
Kalshi is in early IPO talks at a ~$22B valuation after annualized revenue tripled to about $2B in seven months. Here is the case and the risk.
IPO Window Reopens: Kardigan Pops, Deep Fission Lags
Five IPOs priced and five new S-1s filed the week of June 15, 2026 — biotech soared, nuclear stumbled, and Brookfield queued a $650M data-center deal.
Secondaries Hit Record $240B as GP-Led Deals Take Over
Global secondaries volume hit $240B in 2025, a 48% jump driven by GP-led continuation funds. Jefferies sees a $300B run rate within 24 months.